Home › Funds › ORBIMED ADVISORS LLC › UPB
ORBIMED ADVISORS LLC position in UPB
UPSTREAM BIO INC · Health Care
ORBIMED ADVISORS LLC reported holding 5,693,589 shares of UPB (UPSTREAM BIO INC) in its Q2 2026 13F filing — a position valued at US$39.4M, representing 0.79% of its reported portfolio and ranking #36 among its reported holdings. ORBIMED ADVISORS LLC has disclosed UPB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's UPB position evolved
ORBIMED ADVISORS LLC first disclosed a stake in UPB in Q4 2024 at 5,693,589 shares (US$93.6M). The position peaked in Q4 2025 at 5,693,589 shares, worth US$154.6M. Across 7 filings, ORBIMED ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,693,589 shares valued at US$39.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 5.69M | $93.60M | New |
| Q1 2025 | 5.69M | $34.84M | Hold |
| Q2 2025 | 5.69M | $62.52M | Hold |
| Q3 2025 | 5.69M | $107.10M | Hold |
| Q4 2025 | 5.69M | $154.58M | Hold |
| Q1 2026 | 5.69M | $51.24M | Hold |
| Q2 2026 | 5.69M | $39.40M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UPB and 13F data
UPB (UPSTREAM BIO INC) is a Health Care company. 56 other funds we track also report a position in UPB — the largest reported positions include Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M), Parkman Healthcare Partners LLC (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UPB
- Decheng Capital LLC 2.72M sh · $18.86M · Q2 2026
- Enavate Sciences GP, LLC 2.46M sh · $17.02M · Q2 2026
- Parkman Healthcare Partners LLC 935.25K sh · $6.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 600.95K sh · $4.16M · Q2 2026
- Samsara BioCapital, LLC 353.72K sh · $2.45M · Q2 2026
- Propel Bio Management, LLC 350.39K sh · $2.42M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held UPB?
ORBIMED ADVISORS LLC has disclosed UPB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ORBIMED ADVISORS LLC's current position in UPB?
As of Q2 2026, ORBIMED ADVISORS LLC holds 5.69M shares of UPB (UPSTREAM BIO INC), valued at $39.40M, representing 0.79% of its reported portfolio and ranking #36.
Has ORBIMED ADVISORS LLC been buying or selling UPB?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in UPB. The position peaked in Q4 2025 at 5.69M shares.
Which other funds hold UPB?
Other major institutional holders of UPB include Decheng Capital LLC, Enavate Sciences GP, LLC, Parkman Healthcare Partners LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.